Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Schil PE, Van; P, Baas; R, Gaafar; AP, Maat; de Pol M, Van; B, Hasan; HM, Klomp; AM, Abdelrahman; J, Welch; Meerbeeck JP, van

doi:10.1183/09031936.00039510

Public

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Shared by NobleBlocks on Jun 4, 2010 • 12:00 AM UTC

Authors:

Van Schil PE

Baas P

Gaafar R

Abstract

The European Organisation for Research and Treatment of Cancer (EORTC; protocol 08031) phase II trial investigated the feasibility of trimodality therapy consisting of induction chemotherapy followed by extrapleural pneumonectomy and post-operative radiotherapy in patients with malignant pleural mes...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!